AIM ImmunoTech(AIM.US)

Last Updated 19:00:00 ET
longbridge loading

12 Health Care Stocks Moving In Monday's After-Market Session

benzinga_article·
US
BLRX
-6.21%
US
NCNA
-6.88%
US
CDT
-13.04%
benzinga_article·
US
BLRX
-6.21%
US
NCNA
-6.88%
US
CDT
-13.04%

AIM ImmunoTech shares are trading higher. The company reported Q1 financial results.

benzinga_article·
US
AIM
+61.26%
benzinga_article·
US
AIM
+61.26%

12 Health Care Stocks Moving In Monday's Pre-Market Session

benzinga_article·
US
GOSS
-43.32%
US
LTRN
-4.46%
US
AIM
+61.26%
benzinga_article·
US
GOSS
-43.32%
US
LTRN
-4.46%
US
AIM
+61.26%

AIM ImmunoTech | 10-Q: FY2026 Q1 Revenue Beats Estimate at USD 22 K

Earnings Watch·
US
AIM
+61.26%
Earnings Watch·
US
AIM
+61.26%

AIM ImmunoTech Posts Virtual Investor Key Opinion Leader Segment Spotlighting Ampligen Breakthrough Data in Pancreatic Cancer | AIM Stock News

StockTitan·
US
AIM
+61.26%
US
BIB
-3.74%
US
IHE
-0.44%
StockTitan·
US
AIM
+61.26%
US
BIB
-3.74%
US
IHE
-0.44%

12 Health Care Stocks Moving In Friday's Intraday Session

benzinga_article·
US
AMN
+0.87%
US
MRVI
-1.69%
US
INO
-6.15%
benzinga_article·
US
AMN
+0.87%
US
MRVI
-1.69%
US
INO
-6.15%

U.S. Stock Movement Update: Phoenix Asia surged 143%, AIM ImmunoTech fell 34.77%, attracting attention

Price Alert·
US
PHOE
-4.58%
US
AIM
+61.26%
Price Alert·
US
PHOE
-4.58%
US
AIM
+61.26%

AIM ImmunoTech Launches Warrant Inducement; Expects ~$4.2 Million, Hires Ladenburg Thalmann

TradingView·
US
AIM
+61.26%
US
ARKG
-0.14%
US
PBE
-0.58%
TradingView·
US
AIM
+61.26%
US
ARKG
-0.14%
US
PBE
-0.58%
© 2026 Longbridge｜Disclaimer